PharmaShots Connects Brands & Decision-Makers with Custom Media Solutions PharmaShots Provides Curated News & Insights for the Biopharma & Healthcare Industry PharmaShots is Empowering Decision Makers with Actionable Insights Amplify Your Brand with PharmaShots’ Expert Content Creation & Marketing Solutions PharmaShots Enables Brands to Strategically Connect with Their Target Audiences Deliver Your News to the Right Audience with PharmaShots Newswire CXO TALKS CXO TALKSPharmaShots CXO Talks | Women’s History Month Special: A Conversation with Dr. Emanuela Offidani of Tris Pharma CXO TALKSPharmaShots CXO Talks | A Conversation with Liz Benditt, Founder & CEO, The Balm Box CXO TALKSCXO Talks: Vikas Sharma Reveals QurAlis’ Bold Vision for the Future of Neuroscience CXO TALKSCXO Talks: Josh Wittner from Gene By Gene in a Riveting Conversation with PharmaShots EXCLUSIVE INTERVIEW EXCLUSIVEExclusive: A Stimulating Dialogue with Edmund Ben Ami, Co-Founder & CEO of NeuraLight EXCLUSIVEExclusive: Dr. Mónica Domínguez from Smile Train in a Stimulating Conversation with PharmaShots on Why a Healthy Mouth is a Happy Mind EXCLUSIVEExclusive: Kenneth Sake from Blueprint Medicines in an Enlightening Conversation with PharmaShots EXCLUSIVEExclusive Coverage: Dr. Ikshit Sharma from AIMIL Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEAdvancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEDecoding Approval: Moitreyee Chatterjee-Kishore from Astellas in an Exclusive Conversation with PharmaShots EXCLUSIVEAdvancing Urothelial Carcinoma Care: Ahsan Arozullah from Astellas Pharma in an Exclusive Interview with PharmaShots EXCLUSIVEExclusive: David Esposito in an Illuminating Discussion with PharmaShots LATEST NEWSStay up-to-date Merck Receives the EC Approval for Keytruda, Plus CT ± Avastin to Treat PD-L1+ Pt-Resistant Ovarian Carcinoma 6 hours ago Biocytogen and Sihuan Pharmaceutical Partner to Discover Novel Therapeutics in Multiple Indications 7 hours ago AstraZeneca Reports the P-III (EMERALD-3) Trial Data on Imfinzi Combination + TACE in Unresectable Hepatocellular Carcinoma 8 hours ago Cogent Biosciences Reports US FDA’s NDA Submission of Bezuclastinib for Gastrointestinal Stromal Tumors (GIST) 10 hours ago JenaValve Launches Trilogy Transcatheter Heart Valve System in the US to Treat Symptomatic, Severe Aortic Regurgitation (ssAR) 11 hours ago Eli Lilly Reports US FDA Approval of Foundayo (Orforglipron) for Weight Loss 12 hours ago Read More Your Daily Dose of Biopharma News & Insights Delivered to Your Inbox. Join the PharmaShots Family of 20000+ subscribers Subscribe Now
Merck Receives the EC Approval for Keytruda, Plus CT ± Avastin to Treat PD-L1+ Pt-Resistant Ovarian Carcinoma 6 hours ago
Biocytogen and Sihuan Pharmaceutical Partner to Discover Novel Therapeutics in Multiple Indications 7 hours ago
AstraZeneca Reports the P-III (EMERALD-3) Trial Data on Imfinzi Combination + TACE in Unresectable Hepatocellular Carcinoma 8 hours ago
Cogent Biosciences Reports US FDA’s NDA Submission of Bezuclastinib for Gastrointestinal Stromal Tumors (GIST) 10 hours ago
JenaValve Launches Trilogy Transcatheter Heart Valve System in the US to Treat Symptomatic, Severe Aortic Regurgitation (ssAR) 11 hours ago
